These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34520400)

  • 1. Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis.
    Gajjala PR; Kasam RK; Soundararajan D; Sinner D; Huang SK; Jegga AG; Madala SK
    JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34520400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
    Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
    J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
    Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
    J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
    Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
    JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
    Sontake V; Kasam RK; Sinner D; Korfhagen TR; Reddy GB; White ES; Jegga AG; Madala SK
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition.
    Wang Q; Liu J; Hu Y; Pan T; Xu Y; Yu J; Xiong W; Zhou Q; Wang Y
    Theranostics; 2021; 11(14):7110-7125. PubMed ID: 34093874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing.
    Peyser R; MacDonnell S; Gao Y; Cheng L; Kim Y; Kaplan T; Ruan Q; Wei Y; Ni M; Adler C; Zhang W; Devalaraja-Narashimha K; Grindley J; Halasz G; Morton L
    Am J Respir Cell Mol Biol; 2019 Jul; 61(1):74-85. PubMed ID: 30848683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
    Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the K
    Organ L; Bacci B; Koumoundouros E; Kimpton WG; Samuel CS; Nowell CJ; Bradding P; Roach KM; Westall G; Jaffar J; Snibson KJ
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):539-550. PubMed ID: 28060543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase (MMP)-19-deficient fibroblasts display a profibrotic phenotype.
    Jara P; Calyeca J; Romero Y; Plácido L; Yu G; Kaminski N; Maldonado V; Cisneros J; Selman M; Pardo A
    Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L511-22. PubMed ID: 25575513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.